JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (11): 1098-1100.doi: 10.3969/j.issn.1005-6483.2022.11.029
Previous Articles
Received:
Accepted:
Online:
Published:
Abstract: Biliary tract cancer is one of the digestive system malignances with very poor prognosis.Majority of patients belongs to the advanced stage when diagnosed.Currently,systemic chemotherapy is the standard first-line treatment option for advanced biliary tract cancer.However,the clinical efficacy is not satisfactory.A new era has been coming while the immunotherapy is introduced in the treatment of hepatobiliary cancers.Many clinical studies have been conducted in the treatment of biliary tract cancer with immune checkpoint inhibitor drugs,and the clinical efficacy and safety are acknowledged by the clinicians.Meanwhile,further studies should focus on how to treat biliary tract cancer with immunotherapy drugs more precisely.
Key words: biliary tract cancer, immunotherapy, immune checkpoint inhibitors, chemotherapy, combine therapy
ZHU Xingwu, QIU Maixuan, LI Jing. Progress of immunotherapy in advanced biliary tract cancer[J].JOURNAL OF CLINICAL SURGERY, 2022, 30(11): 1098-1100.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://www.lcwkzz.com/EN/10.3969/j.issn.1005-6483.2022.11.029
http://www.lcwkzz.com/EN/Y2022/V30/I11/1098
Cited